Operator
Good evening, and welcome to Oyster Point Pharma s first-quarter 2021 earnings conference call. My name is Sarah, and I will be your operator today. After the company s formal remarks, there will be a question-and-answer session. At this time, I would like to turn the call over to Mr.
Daniel Lochner, Oyster Point Pharma s chief financial officer. Please go ahead.
Dan Lochner
Chief Financial Officer
Good evening, everyone, and welcome to the Oyster Point Pharma first-quarter earnings conference call for the three months ending March 31, 2021. This issued a press release containing our first-quarter financial results and recent business highlights. In addition, our earnings press release and our Form 10-Q that was filed with the SEC after the close of the market today are available on our website under the investor and news section at www.oysterpointrx.com. Joining us on our call today are Dr.
Faces of Fauquier: She posts a âcornyâ joke a day
âAs long as itâs fun and people like it, Iâll do it for a while,â Cathy Stern says of posting âcorny jokesâ every day on Facebook. I want to make sure that every joke I send out, you could take it anywhere. You could take it to church and it would be funny. You could take it to a bar. Itâs just funny. Thereâs no agenda.
By .(JavaScript must be enabled to view this email address)
Staff Journalist It didnât take long for COVID-19 to turn life upside down.
Share this article
Share this article
NEWPORT BEACH, Calif., May 5, 2021 /PRNewswire/ Ceyeber s intraocular lenses are designed for medical applications and will be medical-grade. To ensure expert clinical advisory is at the core of every fundamental decision, Ceyeber has created a Medical Advisory Board consisting of top ophthalmologists. We are thrilled to engage such leading ophthalmologists in this very exciting endeavor in advanced human cybernetics through ocular smart implantable technologies. The following are the members of Ceyeber s Advisory Board. Ceyeber s founder and CEO, Robert E. Grant, said, we look forward to expanding our advisory board and increasing our engagement as we continue to achieve key developmental milestones. In addition, Ceyeber s parent company, Strathspey Crown Holdings, was established by over 600 specialty doctors, including 200+ ophthalmologists from around the world.
Digital health startup Engage Technologies Group raises $15M for patient education tools
April 29, 2021 at 3:11 pm News Brief
Boise, Id.-based Engage Technologies Group closed a $15 million Series A funding round for its mobile patient platform targeted for the cosmetic, optometry, dental, and orthopedic industries.
Founded in 2016, Engage Technologies’ platform allows patients to access educational video content about routine procedures and care. The healthcare startup was founded by CEO Michael Boerner. Total funding to date is $20 million.
The company will use the funds to enter new markets and develop more video content. The funding comes from individual healthcare professionals, the majority of whom are customers.
iOR Partners Welcomes Richard Lindstrom to their Board
Share Article
Renowned ophthalmologist and industry trailblazer brings added expertise to iOR Partners, the pioneer in ophthalmic office-based surgery.
Renowned surgeon and industry trailblazer, Richard Lindstrom, MD, joins iOR Partners Board of Directors
I’m excited to be joining the Board of iOR Partners. I see the trend in ophthalmology of moving away from the HOPD to an ASC or office-based surgery suite as in motion, accelerating, appropriate and necessary. KANSAS CITY, Mo. (PRWEB) April 28, 2021 iOR Partners, the pioneer in office-based surgery (OBS) in the field of ophthalmology announced that renowned surgeon and industry trailblazer, Richard Lindstrom, has joined their Board of Directors.